📢 Important Update: Mounjaro (Tirzepatide) Weight Loss Injections

We’ve received a high volume of enquiries recently following media coverage of Mounjaro (Tirzepatide). Please note the following eligibility criteria apply:

 🔍 Eligibility Criteria (Cohort 2):

To be considered for treatment when available, patients must meet all the following:

✅ BMI over 35

        OR

        BMI over 32.5 for individuals from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds

 ✅ Completion of at least 2 years in a Tier 2 weight management programme

 ✅ At least 4 out of 5 of the following conditions:

 ·         Hypertension

 ·         Atherosclerotic cardiovascular disease

 ·         Obstructive sleep apnoea

 ·         Dyslipidaemia

 ·         Type 2 diabetes

 ⚠️ Access will be subject to ICB Prior Approval. This medication cannot be prescribed on request or without proper assessment.

 ❌ If you do not meet the strict criteria, appointments to discuss weight loss injections will not be booked.

 🔒 For those exploring private treatment, please contact private providers directly. Unfortunately, we are unable to assist with private access or offer advice on private options, monitoring, or providers.

🙏 Thank you for your patience and understanding.

Published on 9 July 2025